KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Bausch Health Companies (BHC) EBIAT (2016 - 2026)

Bausch Health Companies' EBIAT history spans 18 years, with the latest figure at -$1.4 billion for Q1 2026.

  • On a quarterly basis, EBIAT fell 2353.45% to -$1.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$1.2 billion, a 3451.43% decrease, with the full-year FY2025 number at $120.0 million, up 266.67% from a year prior.
  • EBIAT hit -$1.4 billion in Q1 2026 for Bausch Health Companies, down from -$149.0 million in the prior quarter.
  • Over the last five years, EBIAT for BHC hit a ceiling of $403.0 million in Q3 2022 and a floor of -$1.4 billion in Q1 2026.
  • Historically, EBIAT has averaged -$128.7 million across 5 years, with a median of -$69.0 million in 2022.
  • Biggest five-year swings in EBIAT: soared 1380.0% in 2025 and later tumbled 2353.45% in 2026.
  • Tracing BHC's EBIAT over 5 years: stood at -$423.0 million in 2022, then soared by 90.78% to -$39.0 million in 2023, then soared by 351.28% to $98.0 million in 2024, then tumbled by 252.04% to -$149.0 million in 2025, then crashed by 855.03% to -$1.4 billion in 2026.
  • Business Quant data shows EBIAT for BHC at -$1.4 billion in Q1 2026, -$149.0 million in Q4 2025, and $181.0 million in Q3 2025.